VIM and rheumatoid arthritis: Initially, we expected that exPKM2 might be released from activated RA-FLSs, which exhibit the characteristics of cancer cells, including high metabolic activity, migration and invasion into surrounding tissue, since vimentin-expressing RA-FLSs showed the highest PKM2 expression (Fig. 1).